Clinical Trial Detail

NCT ID NCT03727789
Title CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

melanoma

sarcoma

Therapies

CBL0137

Age Groups: adult senior

No variant requirements are available.